Literature DB >> 8523084

New therapies of primary CNS lymphomas and oligodendrogliomas.

D R Macdonald1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8523084     DOI： 10.1007/bf01052666

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  22 in total

1.  Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma.

Authors:  M J Winger; D R Macdonald; J G Cairncross
Journal:  J Neurosurg       Date:  1989-10       Impact factor: 5.115

2.  The role of postoperative irradiation in the treatment of oligodendroglioma.

Authors:  D E Gannett; W M Wisbeck; D L Silbergeld; M S Berger
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-10-15       Impact factor: 7.038

3.  Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome.

Authors:  J Glass; M L Gruber; L Cher; F H Hochberg
Journal:  J Neurosurg       Date:  1994-08       Impact factor: 5.115

4.  Combined modality therapy for primary CNS lymphoma.

Authors:  L M DeAngelis; J Yahalom; H T Thaler; U Kher
Journal:  J Clin Oncol       Date:  1992-04       Impact factor: 44.544

5.  The clinical spectrum of ocular lymphoma.

Authors:  K Peterson; K B Gordon; M H Heinemann; L M DeAngelis
Journal:  Cancer       Date:  1993-08-01       Impact factor: 6.860

6.  Oligodendroglioma: the Rotterdam-Dijkzigt experience.

Authors:  J M Kros; H Pieterman; C G van Eden; C J Avezaat
Journal:  Neurosurgery       Date:  1994-06       Impact factor: 4.654

7.  Increasing incidence of primary brain lymphoma in the US.

Authors:  N L Eby; S Grufferman; C M Flannelly; S C Schold; F S Vogel; P C Burger
Journal:  Cancer       Date:  1988-12-01       Impact factor: 6.860

8.  The treatment of anaplastic oligodendrogliomas and mixed gliomas.

Authors:  A P Kyritsis; W K Yung; J Bruner; M J Gleason; V A Levin
Journal:  Neurosurgery       Date:  1993-03       Impact factor: 4.654

9.  Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS.

Authors:  P A Forsyth; J Yahalom; L M DeAngelis
Journal:  Neurology       Date:  1994-08       Impact factor: 9.910

10.  Oligodendrogliomas: the Mayo Clinic experience.

Authors:  E G Shaw; B W Scheithauer; J R O'Fallon; H D Tazelaar; D H Davis
Journal:  J Neurosurg       Date:  1992-03       Impact factor: 5.115
View more
  2 in total

1.  Necrotizing vasculopathy of the CNS: case report.

Authors:  Martin Begemann; George Krol; Marc K Rosenblum; Lisa M Deangelis
Journal:  J Neurooncol       Date:  2005-04       Impact factor: 4.506

2.  Hyperosmolar and methotrexate therapy avoiding surgery in the acute presentation of primary central nervous system lymphoma.

Authors:  Bryan S Lee; Rupa G Juthani; Andrew T Healy; David M Peereboom; Violette M Recinos
Journal:  Surg Neurol Int       Date:  2014-07-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.